Neurosciences Offer Researchers Diverse Opportunities

if (n == null) The Scientist - Neurosciences Offer Researchers Diverse Opportunities The Scientist 13[18]:26, Sep. 13, 1999 Profession Neurosciences Offer Researchers Diverse Opportunities By James Kling Great promise for advances in neuroscience existed at the beginning of the Decade of the Brain. Like most life science disciplines, neuroscience had benefited from huge strides in molecular biology, and many expected neuromuscular diseases such as multipl

Written byJames Kling
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share


Profession

Great promise for advances in neuroscience existed at the beginning of the Decade of the Brain. Like most life science disciplines, neuroscience had benefited from huge strides in molecular biology, and many expected neuromuscular diseases such as multiple sclerosis and Parkinson's disease to be vanquished quickly. Not surprisingly, public anticipation has gone unfulfilled as this decade winds down. Neuroscience has made great progress, but most of its therapeutic application is still years away.


Chris Fibiger
Even if public expectations remain unmet, neuroscience has only scratched the surface of the brain. Technical advances and discoveries have led to new and deeper questions concerning neuroscience and neurological disorders. Because neurological diseases, including Alzheimer's, Parkinson's, multiple sclerosis, and psychological disorders, are so costly--and because the aging U.S. population is becoming more susceptible to such disorders--government and industry are funneling research money into neurological research.

And that means jobs. It also means ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies